Rasonable, Roberto B.

HRN: 07-90-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFTRIAXONE 1G (VIAL)
09/25/2025
10/02/2025
IVTT
2g
Q24H
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines